Company attributes
Industry
Location
B2X
CEO
Founder
Date Incorporated
2017
Number of Employees (Ranges)
51 – 200
Full Address
101 E 6TH St Ste 300 Vancouver, WA, 98660-3342 United States
CIK Number
Investors
Total Funding Amount (USD)
222,500,000
Latest Funding Round Date
March 2021
Latest Funding Type
Patents Assigned (Count)
2
Other attributes
Company Operating Status
Closed
AbSci, LLC is an AI-powered synthetic biology company employing their Integrated Drug Creation™ Platform to accelerate discovery of novel biotherapeutic drug candidates.
Timeline
No Timeline data yet.
